Holista Colltech Limited
Holista Colltech Limited (HCT.AX) Stock Overview
Explore Holista Colltech Limited’s financial performance, market position, analyst ratings, and future outlook.
Key Financials
Key Financials
Market Cap
21.8M
P/E Ratio
-215.11
EPS (TTM)
$-0.02
ROE
0.04%
HCT.AX Stock Analysis & Investment Overview
Our comprehensive AI-powered analysis of Holista Colltech Limited (HCT.AX) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.
The current technical analysis reveals key indicators including an RSI of 66.77, suggesting the stock is in a neutral condition. Our forecasting models predict significant price movements, with a 12-month target of $0.01.
Key financial metrics showcase the company's fundamental strength, including a P/E ratio of -215.11 and a market capitalization of 21.8M. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.
Technical Indicators
Company Profile
Holista CollTech Limited operates as a biotech company in Australia, Malaysia, and the United States. The company operates through Supplements, Ovine Collagen, Infection control Solutions, and Food Ingredients segments. It manufactures and wholesales dietary supplements; cosmetic grade collagen; and healthy food ingredients, including low-glycaemic index (GI) flour mix for noodles, pasta, flatbreads and other baked products, low-sodium salt, low-fat fried foods, less-calorie sugar, and low-GI sugar. The company also provides infection control solutions. Holista CollTech Limited is based in Subiaco, Australia.
Leong Man Loong
3
283 Rokeby Road, Subiaco, WA
2003